Soleno Therapeutics Inc. Daily Stock Analysis

Daily Stock Analysis, SLNO, Soleno Therapeutics Inc, priceseries

Soleno Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
0.32
Close
0.30
High
0.32
Low
0.30
Previous Close
0.31
Daily Price Gain
-0.01
YTD High
0.48
YTD High Date
Jan 5, 2022
YTD Low
0.27
YTD Low Date
Jan 24, 2022
YTD Price Change
-0.14
YTD Gain
-31.93%
52 Week High
1.78
52 Week High Date
Mar 16, 2021
52 Week Low
0.27
52 Week Low Date
Jan 24, 2022
52 Week Price Change
-1.08
52 Week Gain
-78.25%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jul 24. 2017
2.93
Jul 25. 2017
3.22
1 Trading Days
9.63%
Link
LONG
Aug 24. 2017
1.98
Sep 8. 2017
2.57
10 Trading Days
30.22%
Link
LONG
Jan 11. 2018
1.86
Jan 24. 2018
1.97
8 Trading Days
5.75%
Link
LONG
Mar 2. 2018
1.74
Mar 14. 2018
1.85
8 Trading Days
6.33%
Link
LONG
Jun 12. 2018
2.07
Jun 26. 2018
2.47
10 Trading Days
19.34%
Link
LONG
May 22. 2019
2.03
Jun 6. 2019
2.63
10 Trading Days
29.62%
Link
LONG
Dec 24. 2019
2.79
Dec 27. 2019
2.95
2 Trading Days
5.73%
Link
LONG
Apr 7. 2020
2.47
Apr 20. 2020
2.74
8 Trading Days
10.81%
Link
LONG
May 18. 2020
3.41
May 27. 2020
3.62
6 Trading Days
6.01%
Link
LONG
Jun 29. 2020
2.08
Jul 1. 2020
2.19
2 Trading Days
5.05%
Link
LONG
Sep 4. 2020
2.04
Sep 10. 2020
2.16
3 Trading Days
5.64%
Link
LONG
Nov 3. 2020
1.78
Nov 17. 2020
1.97
10 Trading Days
10.69%
Link
LONG
Feb 1. 2021
2.06
Feb 22. 2021
2.89
14 Trading Days
40.41%
Link
Company Information
Stock Symbol
SLNO
Exchange
NasdaqCM
Company URL
http://www.capnia.com
Company Phone
650-213-8444
CEO
Anish Bhatnagar
Headquarters
California
Business Address
1235 RADIO ROAD, SUITE 110, REDWOOD CITY, CA 94065
Sector
Equity
Industry Category
Drugs
Industry Group
Diagnostic Substances
CIK
0001484565
About

CAPNIA, Inc. is a diversified healthcare company, which develops novel products based on company proprietary technologies for precision metering of gas flow. It also develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. Its products include CoSense and Serenz. The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Description

Capnia, Inc. develops and commercializes therapeutics and diagnostics products. The company offers CoSense for the diagnosis of excessive hemolysis in neonates, a condition that causes long-term developmental disability due to degradation of red blood cells. It also develops Serenz, a therapeutic product candidate that has completed Phase II clinical trials for the treatment of symptoms related to allergic rhinitis. The company was founded in 1999 and is based in Redwood City, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading